We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





AACC Advises Against Using Coronavirus Test CT Values to Guide COVID-19 Patient Care

By HospiMedica International staff writers
Posted on 09 Jul 2021
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) has issued a public statement advising against the use of coronavirus test cycle threshold (Ct) values to guide COVID-19 treatment or public health efforts.

The medical community has become increasingly interested in the possibility of using coronavirus test Ct values to improve care for COVID-19 patients and overall management of the pandemic. More...
When a patient gets a standard coronavirus test - known as a qualitative PCR test -Ct values are generated as part of the testing process. These values typically have an inverse relationship with the amount of virus in a patient specimen, with low Ct values indicating a high amount of virus in a sample, and high Ct values indicating the reverse. Because of this, some research has suggested that Ct values could potentially identify patients who have high viral loads and are at increased risk for serious disease. Other findings have also indicated that Ct values could potentially identify patients who aren’t infectious (i.e. those with low viral loads), which could improve contact tracing and outbreak tracking efforts.

However, conclusive data supporting the use of Ct values are lacking. In spite of these studies, many others in the medical community have cautioned against the use of Ct values, arguing that these values have numerous shortcomings and can’t reliably predict disease severity or transmissibility. In order to bring clarity to this issue, AACC members have released a statement that details the limitations of Ct values and recommends against their use. The statement emphasizes that, even though Ct values correlate with the amount of virus in specific specimens, studies have not actually established a relationship between Ct values and a patient’s overall viral load or infectiousness.

There are also numerous factors aside from the amount of virus in a specimen that can impact the Ct values generated during coronavirus testing. AACC’s statement lists all of these factors, which include variables such as patient age, the test instruments used, and even whether or not a patient blows their nose before sample collection. Even with these limitations, though, AACC’s statement acknowledges that clinicians might still want access to Ct values in certain circumstances. If clinical laboratories decide to report Ct values to clinicians who request them, the association recommends that labs include a prominent comment with every report explaining that the use of Ct values to guide patient management is discouraged and why.

“Along with the vaccines, coronavirus testing continues to play a critical role in managing the COVID-19 pandemic around the world,” said AACC President Dr. David G. Grenache. “AACC’s experts have therefore put together this document to provide much-needed guidance on this particular area of coronavirus testing, and to ensure that coronavirus PCR tests continue to be used in a way that best serves patient and public health needs.”

Related Links:
AACC


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.